DIFFERENTIAL-EFFECTS OF VARIOUS CA-2+ ANTAGONISTS

被引:150
作者
FARRE, AJ
COLOMBO, M
FORT, M
GUTIERREZ, B
机构
来源
GENERAL PHARMACOLOGY | 1991年 / 22卷 / 01期
关键词
D O I
10.1016/0306-3623(91)90331-Y
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The effects of various Ca antagonists (nicardipine, nifedipine, verapamil, diltiazem, flunarizine, cinnarizine, lidoflazine and papaverine) were studied in one in vitro (inhibition of CaCl2 induced contractions in isolated rat aorta) and two in vivo tests [survival after BaCl2 in the rat and survival after arachidonic acid (AA) in the mouse]. 2. Test substances behave in different ways, thus suggesting varying mechanisms of action. 3. The three tests used are very simple and quick to perform, but taken together give a good preliminary information which allows classification of the products during the screening phase into four subgroups: dihydropyridines, verapamil, diltiazem and diphenylalkylamines.
引用
收藏
页码:177 / 181
页数:5
相关论文
共 18 条
[1]  
[Anonymous], 1970, PHARM EXPT ISOLATED
[2]  
DECLERCK F, 1985, ARCH INT PHARMACOD T, V274, P4
[3]   CALCIUM-ANTAGONIST SUBGROUPS [J].
DEFEUDIS, FV .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1985, 6 (06) :237-238
[4]   SPECIFIC PHARMACOLOGY OF CALCIUM IN MYOCARDIUM, CARDIAC-PACEMAKERS, AND VASCULAR SMOOTH-MUSCLE [J].
FLECKENSTEIN, A .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1977, 17 :149-166
[5]   CALCIUM-ANTAGONISTS - MECHANISMS AND THERAPEUTIC USES [J].
FLECKENSTEINGRUN, G ;
FREY, M ;
FLECKENSTEIN, A .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1984, 5 (07) :283-286
[6]  
FURCHGOTT RF, 1961, METHOD MED RES, V8, P177
[7]  
Garcia Rafanell J, 1982, J Pharmacol Methods, V7, P231
[8]   CALCIUM CHANNELS - DIRECT IDENTIFICATION WITH RADIOLIGAND BINDING-STUDIES [J].
GLOSSMANN, H ;
FERRY, DR ;
LUBBECKE, F ;
MEWES, R ;
HOFMANN, F .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1982, 3 (11) :431-437
[9]  
LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
[10]  
PIASCIK MF, 1978, J PHARMACOL EXP THER, V205, P155